ID
15566
Beskrivning
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany Part: Baseline: Repitition of Assessments
Länk
https://clinicaltrials.gov/ct2/show/NCT02419378
Nyckelord
Versioner (3)
- 2016-06-03 2016-06-03 -
- 2016-06-03 2016-06-03 -
- 2016-06-03 2016-06-03 -
Uppladdad den
3 juni 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0 Legacy
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Baseline: Repitition of Assessments: MRI Multiple Sclerosis ALAIN01 NCT02419378
Baseline: Repitition of Assessments: MRI Multiple Sclerosis ALAIN01 NCT02419378
Similar models
Baseline: Repitition of Assessments: MRI Multiple Sclerosis ALAIN01 NCT02419378
C1711411 (UMLS CUI [1,2])
C0024485 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,2])
C0032976 (UMLS CUI [1,2])
C0032976 (UMLS CUI [1,2])
C1550373 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,2])
C1333400 (UMLS CUI [1,2])
C2700066 (UMLS CUI [1,2])
C2700066 (UMLS CUI [1,2])
C2697938 (UMLS CUI [1,2])
C2697938 (UMLS CUI [1,2])
C1519316 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])